Gastrointestinal

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC34-3

DiraChart Clinical Reference
Protected section 3 of 26
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 26PreviousNext

2. What the clinician must assess

A complete assessment addresses each of the following each visit, scaled to the patient's diagnosis and stability:

  • The abdominal examination — inspection (distension and contour), auscultation (bowel sounds in all quadrants), and palpation (tenderness, guarding, rigidity, rebound, and masses).
  • Bowel function — the last bowel movement, frequency, and consistency (a Bristol assessment), and constipation, diarrhea, or incontinence.
  • Nausea and vomiting and their character — bilious, or bloody or coffee-ground (which signals bleeding).
  • Appetite and early satiety (detailed intake in Nutrition).
  • GI bleeding signs — hematemesis, melena, or hematochezia.
  • An ostomy, when present — stoma appearance and viability, output, the appliance, and the peristomal skin.
  • GI symptoms — heartburn, dysphagia (with Taste / Swallowing), and abdominal pain (characterized in Pain).
  • Medications affecting the GI tract (for example opioids causing constipation) and the hydration impact (with Hydration).
Section NavigationPart 3 of 26PreviousNext